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trust in SLIPS is associated with greater likelihood to participate in
school-located immunization programs.
Sources of Support: SAHM Public Demonstration Grants through
Merck.
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Purpose: HPV vaccination uptake has plateaued compared to its
adolescent vaccine counterparts. With persistently low pro-
portions of adolescents receiving HPV vaccination, the true bene-
ﬁts of a safe and effective vaccine cannot be fully achieved.
To increase HPV vaccination, we sought to determine social and
behavioral factors that may contribute to vaccination uptake.
Methods: Data were obtained frommale and female patients, ages
11-21 at an outpatient pediatric and adolescent clinic in the South.
Demographics, insurance status and HPV vaccination history were
obtained through electronic medical record abstraction. The
self-administered Guidelines for Adolescent Prevention Services
cross-sectional survey was used to collect data on health, risk and
protective behaviors. Chart abstraction and survey data were
combined and analyzed using STATA 12.0. Univariate analysis was
used to evaluate sample characteristics and bivariate chi-square
analysis assessed associations between demographics, insurance
and behaviors on HPV vaccination initiation and completion.
Results: 314 adolescents (48% male, 52% female, 21% white; 45%
black, 27% Hispanic, 8% other) participated. Most had public in-
surance or were uninsured (82%). 36% of teens had initiated HPV
vaccination; 43% completed vaccination. Therewere no differences
in HPV vaccination initiation or completion between those with
public or private insurance or uninsured. There were differences in
vaccination uptake by race, but these differences were not statis-
tically signiﬁcant. Females were more likely to complete vaccina-
tion than males (54% vs. 32%, x2<0.001). Increasing age was also
associated with HPV vaccination completion (x2<0.001). At age 11,
75% had begun the HPV vaccination series, but none had
completed it. The greatest initial peak of HPV vaccination
completion occurred at age 15, where 61% of 15 year olds had
completed vaccination, compared with 38% of 12 year olds, 33% of
13 year olds and 52% of 14 year olds. Teens who reported currently
dating (56%), prior sexual activity (61%), having sexually active
friends (60%), or using pregnancy prevention methods (56%) were
more likely to complete HPV vaccination than those who did not
(x2<0.05). Teens who reported their parents discussing sex with
them were more likely to complete vaccination than those whose
parents did not discuss sex with them or those who were unsure
(47% vs. 24% vs. 32%, x2¼ 0.014). No other personal risk behavior
measured: eating/weight/body, schools, weapons/violence/safety,
tobacco, substance use, emotions or special circumstances were
signiﬁcantly associated with HPV vaccination.
Conclusions: Among the measured demographics and behaviors
surveyed, only female gender, age, parent discussion of sex, and
teen sexual behaviors were associated with HPV vaccination
initiation and/or completion. While encouraging that sexually
experienced adolescents were more likely to be vaccinated, it is
important to ensure vaccination of young adolescents prior tosexual activity and emphasize HPV vaccination of males. Since
parent communication about sex was associated with increased
vaccination, future interventions incorporating parent discussions
of sex may be effective and should be explored.
Sources of Support: R.H.G was supported through an award from
The U.S. Health Resources and Services Administration (HRSA),
D34HP16299.
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Purpose: Application of text messaging by health care providers
among adolescent patients is often shaped by provisions for
keeping information about health care encounters among ado-
lescents conﬁdential from their parents or guardians. We exam-
ined text messaging enrollment patterns among adolescents and
their guardians to determine whether adolescents and their par-
ents seek similar partitioning of information.
Methods: Data were drawn from a study offering text message
appointment reminders to adolescents (ages 11-21) and/or their
parents for the HPV vaccine in a single urban clinic in an academic
medical center. Adolescents receiving either the ﬁrst or second
HPV vaccine in the 3-dose series were offered the option of
receiving text message appointment reminders for subsequent
doses. Adolescents were offered the option of having reminders
sent to their phone, to the phone of a parent or guardian, or to both.
During the consent process, each potential participant (adolescent
or parent) was reminded of adolescents’ rights to obtain conﬁ-
dential care and that the conﬁdentiality of text messages cannot be
guaranteed. Descriptive and chi-squared analyses were used to
examine recipient preferences and whether these varied by age,
gender, and contract versus pay-as-you-go cellular plans. Based on
analysis of enrollment preference patterns, participants were
grouped by the following age categories: 11-15, 16-17, and 18-21.
Results: In a 4-month period, 211 patients had at least 1 family
member opt to receive appointment reminders for the adolescent’s
next dose of HPV. We had 231 discrete phone numbersd including
20 adolescent and parent pairs jointly enrolleddand only 5 re-
cipients without unlimited texting and 68 pay-as-you-go plans (vs
162 contract vs 1 text application). The average age at enrollment
was 14.4 years (Median 13.6 years, SD 2.8). One-quarter (N¼52) of
recipients were adolescents, 65.9% (N¼139) were parent/guardian,
and 9.5% were sent to both the adolescent and parent (N¼20). 112
adolescents enrolled at shot 1 and 99 enrolled at shot 2.
Adolescent preference for having a parent receive reminders
did not vary by gender (p¼0.88); however there were differences
in enrollment patterns by age. Among adolescents ages 11-15,
93.5% of families opted to have text messages sent to the parent
(either alone or in conjunction with the adolescent); of those ages
16-17, 51.8% of adolescents elected to be the sole recipient, while
48.2% elected to have messages sent only to the parent or to both
the parent and adolescent. Of those 18 and older, 90.3% opted to
have all text messages sent only to the adolescent (p<0.001).
Conclusions: In an urban clinic setting, younger adolescents (¼15)
prefer to have parents receive reminders. As adolescents age, they
prefer to be the only recipient of text message reminders. This
Poster Symposia / 54 (2014) S17eS33S32suggests that adolescents and their families can, when given the
option, make informed and reasoned choices about the ﬂow of
information about appointments. Health care providers should
make every effort to provide a range of communication options to
adolescents and not make assumptions about their preferences for
sharing information with parents or guardians.
Sources of Support: SAHM Improving Understanding of Adoles-
cent Vaccination through Innovative Local Public Health Demon-
stration Grant.
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Purpose: Adolescent immunization rates for all vaccines are low
when compared to the high rates of childhood immunization in
the US. This is especially true with multi-dose vaccines, such as
the Human Papilloma Virus (HPV) vaccine. The American Acad-
emy of Pediatrics recommends HPV vaccination for females and
males from 11 to 26 years of age. Missed opportunities for the
HPV vaccine are common. The CDC reports that in 2012, if all
missed opportunities for initiation of HPV vaccination had been
eliminated, coverage with ¼ 1 dose of HPV vaccine could have
reached 92.6%. Even after the vaccine has been initiated, there
are still many occasions for missed opportunities. Adolescents
who are 18-25 years old have particularly low rates of starting
and completing the HPV vaccine. Delayed or non-completion of
HPV series may decrease protection against HPV infection
especially if exposure to HPV occurs prior to completion. Our
objective was to examine HPV series completion in adolescent-
speciﬁc, medicine and family planning clinics and to assess the
frequency of missed opportunities when adolescents come in for
any type of care.
Methods: Electronic medical records were queried for young
women 18-25 years old who initiated the HPV vaccine series in the
Adolescent Medicine, Young Mother’s or Family Planning clinics at
Children’s Hospital Colorado from 1/1/2010 to 12/31/2011. Visits
for preventive or non-preventive care during appropriate dosing
intervals of HPV vaccine where the 2nd (4-14 weeks after 1st dose)
or 3rd (21-40 weeks after 1st dose and >12 weeks after 2nd dose)
doses were not administered were counted as “missed
opportunities.”
Results: 567 females initiated the HPV series during the study
period and 22.2% of these patients completed the full series
within one year of initiation. 33.5% of patients who did not receive
their 2nd dose had at least one missed opportunity visit and 23.8%
of patients who received the 2nd but not 3rd dose had a missed
opportunity for completion. Women who initiated the vaccine in
the Family Planning clinic were less likely to have missed op-
portunities than those who initiated in other adolescent clinics
(29.8% vs. 42.2%; p<0.005). There were no racial or ethnic dif-
ferences between those who completed the series and those who
did not.
Conclusions: A signiﬁcant number of adolescent females who
initiated the HPV vaccine had missed opportunities for continu-
ation and completion. This emphasizes the importance of pro-
vider-awareness of vaccine updates at every adolescent visit. Thelower missed opportunity rate in Family Planning may reﬂect
increased provider knowledge and counseling focused on the
importance of HPV vaccination. Our overall completion rate is
signiﬁcantly lower than previously published rates and may
reﬂect older adolescents’ inexperience in managing their own
preventive health care. Our results clearly identify the need for
provider and patient interventions to improve vaccine series
completion.
Sources of Support: No sources of ﬁnancial support.
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Purpose: HPV is the most common sexually transmitted infection.
The quadrivalent HPV vaccination was approved for use in males
ages 9 to 26 in 2009 and recommended for routine administration
in 2011. The purpose of this study was to uncover predictable
commonalities amongst parents who chose to vaccinate their 11-
17 year old sons against HPV.
Methods:We complied data from a U.S. national sample of parents
with sons 11-17 years old using aweb-based survey. Using a survey
research company (SSI), we collected data from a national sample
of U.S. adults in July and August of 2012. This survey covered
parental demographics, political afﬁliation, and religious service
attendance, parental discussion of sexual health topics with their
sons, son’s health care utilization and recent inﬂuenza vaccination
history.We used binary logistic regression tomodel sons’ receipt of
1 or more doses of HPV vaccine. Behavioral and sociodemographic
predictors were ﬁrst modeled individually for univariate associa-
tions and then signiﬁcant predictors (p<.05) were combined in a
multivariable model. All analyses were performed using SPSS 21.
Results: A total of 779 parents (52% female) with a mean age of 42
years (SD 11.54) completed the survey. Overall, 21.7% of parents
reported that their son had received one or more doses of HPV
vaccine. Increasing parental age was associated with decreased
odds of HPV vaccination (OR 0.98; 95% CI 0.96-0.99). Parents who
had discussed sexual health topics with their sonsweremore likely
to vaccinate (OR 1.61; 95% CI 1.37-1.89). Sons who were evaluated
by healthcare providers sometime in the last year more frequently
received at least one dose of the vaccine (OR 2.22; 95% CI 1.12-4.40)
as did those who had received a ﬂu shot in the last two years (OR
1.82; 95% CI 1.45-2.26). Parent gender, religiosity, political afﬁlia-
tion, parental education, and sons’ age were not signiﬁcant pre-
dictors of HPV vaccination.
Adjusted odds ratios, controlled for ethnicity, conﬁrmed that
parental age (AOR 0.98; 95% CI 0.97-0.99), openness to discuss
sexual health with sons (AOR 1.58; 95% CI 1.33-1.88), and receiving
a ﬂu shot in the last two years (AOR 1.71; 95% CI 1.36-2.15)
remained independent predictors of HPV vaccination in a multi-
variate model.
Conclusions: The rate of male vaccination in this study, although
low, is higher than 2011 national CDC data. There is a signiﬁcant
increase in rate of vaccination in those who have had exposure to
health care providers. Both SAHM, and Bright Futures, recommend
routine care for adolescents. This study suggests that vaccination
rates would increase by following this practice. Additionally, the
